CONTACTStaffCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2024 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
GlaxoSmithKline plans to develop an experimental HIV vaccine that will "piggyback" on a shot against measles. Europe's biggest drug maker and France's Institut Pasteur intend to make the vaccine by fusing genes from HIV with an existing vaccine for the childhood disease, the two organizations said on Monday.
GSK Biologicals--Glaxo's vaccines unit--will license the measles vaccine vector, or carrier, technology from Institut Pasteur, and researchers from both groups will jointly develop the new vaccine.
The project is the latest in a range of novel approaches to fighting HIV, which has killed more than 3.1 million people this year alone. Scientists believe a vaccine is the best hope for ending the epidemic. However, the virus has proved far more difficult for vaccine developers to outwit than anyone anticipated when the first case of AIDS was reported in 1981.
Glaxo believes adapting a measles shot is a promising approach, since the vaccine against this old disease is known to give very long-lasting immunity. The hope is that using it as a carrier to deliver HIV proteins will produce a similarly potent and long-lasting vaccine to prevent AIDS.
There are no guarantees of success, however, and the project will take many years of research before scientists know whether they can manufacture a safe and effective therapy.
The research will be carried out under a public-private collaboration, and the initial project is being supported by a grant of 5.5 million euros from the European Union. Four research centers will be involved in France, Belgium, and Britain, and the partners hope to start clinical studies in about three years.
Public-private partnerships are increasingly being used to tackle diseases, including malaria and tuberculosis, that occur primarily in poor countries where Western pharmaceutical companies stand little chance of making money. In exchange for public sector support, companies agree to make any successful medicines available in developing countries at affordable prices.
Glaxo, like many of its rivals, is pursuing a number of different HIV vaccine ideas. Earlier this year it signed a collaboration with the International AIDS Vaccine Initiative to develop a vaccine using an adapted chimpanzee virus, known as an adenovirus, to carry HIV proteins into cells and trigger an immune response. It also has a third in-house HIV vaccine project, and experts believe any successful vaccine might have to combine a number of such different approaches.
Other companies are also stepping up work in the hunt for a vaccine, with Merck arguably leading the field. In September this year, the U.S. company said it was doubling enrollment in a clinical trial of its leading HIV vaccine candidate following encouraging initial results, though final results of the trial will not be available until at least 2008. (Reuters)
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Here Are Our 2024 Election Predictions. Will They Come True?
November 07 2023 1:46 PM
Meet all 37 of the queer women in this season's WNBA
April 17 2024 11:24 AM
17 Celebs Who Are Out & Proud of Their Trans & Nonbinary Kids
November 30 2023 10:41 AM
Here Are the 15 Most LGBTQ-Friendly Cities in the U.S.
November 01 2023 5:09 PM
Which State Is the Queerest? These Are the States With the Most LGBTQ+ People
December 11 2023 10:00 AM
These 27 Senate Hearing Room Gay Sex Jokes Are Truly Exquisite
December 17 2023 3:33 PM
10 Cheeky and Homoerotic Photos From Bob Mizer's Nude Films
November 18 2023 10:05 PM
42 Flaming Hot Photos From 2024's Australian Firefighters Calendar
November 10 2023 6:08 PM
These Are the 5 States With the Smallest Percentage of LGBTQ+ People
December 13 2023 9:15 AM
Here are the 15 gayest travel destinations in the world: report
March 26 2024 9:23 AM
Watch Now: The Daily
Trending stories from our video partner Advocate Channel.
For more videos and shows go to advocatechannel.com.
Trending stories from our video partner Advocate Channel.
For more videos and shows go to advocatechannel.com.
Latest Stories
Gay Pennsylvania Rep. Malcolm Kenyatta wins Democratic primary for auditor general
April 25 2024 7:30 AM
Meet the transgender minister representing LGBTQ+ rights in Georgia
April 25 2024 6:30 AM
How a lesbian's triumph on the Portland Timbers billboard broke barriers
April 24 2024 4:52 PM
‘Faces of Gun Violence’ exhibit unveiled at inaugural survivors’ summit
April 24 2024 4:46 PM
Trans woman Andrea Doria Dos Passos beaten to death in Miami Beach; arrest made
April 24 2024 4:36 PM
TikTok may be banned in the U.S. after Biden signs new law — Why?
April 24 2024 3:43 PM
Serial killer of gay men in New Orleans released after 46 years in prison
April 24 2024 2:16 PM
The 'largest bi+ event in the world' is happening this year. Here's when and where
April 24 2024 12:42 PM
What happens if Donald Trump is jailed for criminal contempt?
April 24 2024 12:22 PM
Megan Rapinoe, Sue Bird, and more urge NCAA to stand up for trans inclusion
April 24 2024 8:00 AM